Temporal improvements in loco-regional failure and survival in patients with anal cancer treated with chemo-radiotherapy: treatment cohort study (1990-2014)
Fulford, Paul E
Wilson, Malcolm S
O'Dwyer, Sarah T
Saunders, Mark P
Renehan, Andrew G
AffiliationDivision of Cancer Sciences, School of Medical Sciences, Faculty of Biological, Medicine and Health, University of Manchester, Manchester, UK
MetadataShow full item record
AbstractBACKGROUND: We evaluated oncological changes in patients with squamous cell carcinoma of the anus (SCCA) treated by chemoradiotherapy (CRT) from a large UK institute, to derive estimates of contemporary outcomes. METHODS: We performed a treatment-cohort analysis in 560 patients with non-metastatic SCCA treated with CRT over 25 years. The primary outcomes were 3-year loco-regional failure (LRF), 5-year overall survival (OS), and 5-year cancer-specific survival (CSS). We developed prediction models; and overlaid estimates on published results from historic trials. RESULTS: Age distributions, proportions by gender and cT stage remained stable over time. The median follow-up was 61 (IQR: 36-79) months. Comparing the first period (1990-1994) with the last period (2010-2014), 3-year LRF declined from 33 to 16% (Ptrends?<?0.001); 5-year OS increased from 60% to 76% (Ptrends?=?0.001); and 5-year CCS increased from 62% in to 80% (Ptrends?=?0.001). For 2020, the models predicted a 3-year LRF of 14.7% (95% CIs: 0-31.3); 5-year OS of 74.7% (95% CIs: 54.6-94.9); and 5-year CSS of 85.7% (95% CIs: 75.3-96.0). Reported oncological outcomes from historic trials generally underestimated contemporary outcomes. CONCLUSIONS: Current and predicted rates for 3-year LRF and 5-year survivals are considerably improved compared with those in historic trials.
CitationSekhar H, Malcomson L, Kochhar R, Sperrin M, Alam N, Chakrbarty B, et al. Temporal improvements in loco-regional failure and survival in patients with anal cancer treated with chemo-radiotherapy: treatment cohort study (1990-2014). Br J Cancer. 2020.
JournalBritish Journal of Cancer
- Evaluation of factors associated with loco-regional failure and survival in limited disease small cell lung cancer patients treated with chemoradiotherapy.
- Authors: Winther-Larsen A, Hoffmann L, Moeller DS, Khalil AA, Knap MM
- Issue date: 2015
- Definitive chemoradiotherapy for anal canal cancer: single-center experience.
- Authors: Tachibana I, Nishimura Y, Inada M, Fukuda K, Ishikawa K, Nishikawa T, Yokokawa M, Nakamatsu K, Kanamori S, Hida JI
- Issue date: 2018 Dec
- Primary surgery with or without postoperative radiotherapy in early stage squamous cell carcinoma in the anal canal and anal margin.
- Authors: Leon O, Hagberg O, Johnsson A
- Issue date: 2018 Sep
- Tumour- and treatment-related colostomy rates following mitomycin C or cisplatin chemoradiation with or without maintenance chemotherapy in squamous cell carcinoma of the anus in the ACT II trial.
- Authors: Glynne-Jones R, Kadalayil L, Meadows HM, Cunningham D, Samuel L, Geh JI, Lowdell C, James R, Beare S, Begum R, Ledermann JA, Sebag-Montefiore D, ACT II Study Group.
- Issue date: 2014 Aug
- Nodal stage migration and prognosis in anal cancer: a systematic review, meta-regression, and simulation study.
- Authors: Sekhar H, Zwahlen M, Trelle S, Malcomson L, Kochhar R, Saunders MP, Sperrin M, van Herk M, Sebag-Montefiore D, Egger M, Renehan AG
- Issue date: 2017 Oct